These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38758571)

  • 1. High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
    Irvin R; Landry G; Jones MR; James A; Schexnayder J; Rodriguez S; Wendell D; Barthe K; Britton E; LeSar K; Manogue S; Sugarman OK; Brown C; Burgess S; Mehta SH; Thomas DL; Robinson W;
    J Viral Hepat; 2024 Jul; 31(7):432-435. PubMed ID: 38758571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.
    Gahrton C; Westman G; Lindahl K; Öhrn F; Dalgard O; Lidman C; Nilsson LH; Said K; Duberg AS; Aleman S
    BMC Infect Dis; 2019 Nov; 19(1):955. PubMed ID: 31706284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
    Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
    J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
    Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.
    de la Flor C; Porsa E; Nijhawan AE
    Public Health Rep; 2017; 132(6):617-621. PubMed ID: 29045799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
    Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
    BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
    Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
    Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
    Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
    Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
    Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
    J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
    Busschots D; Kremer C; Bielen R; Koc ÖM; Heyens L; Brixko C; Laukens P; Orlent H; Bilaey P; De Smet F; Hellemans G; Muyldermans G; Van Baelen L; Hens N; Van Vlierberghe H; Robaeys G
    BMC Infect Dis; 2021 Jul; 21(1):708. PubMed ID: 34315415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
    Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
    J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
    Kileng H; Gutteberg T; Goll R; Paulssen EJ
    BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.
    Harris AM; Chokoshvili O; Biddle J; Turashvili K; Japaridze M; Burjanadze I; Tsertsvadze T; Sharvadze L; Karchava M; Talakvadze A; Chakhnashvili K; Demurishvili T; Sabelashvili P; Foster M; Hagan L; Butsashvili M; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):466. PubMed ID: 32326938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
    Defante Ferreto LE; Guedes S; Braz Pauli F; Soligo Rovani S; Aní Caovilla Follador F; Paula Vieira A; Himovski Torres R; Colares Coelho H; Welter Wendt G
    PLoS One; 2021; 16(7):e0255173. PubMed ID: 34310633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.
    Abe CM; Aguwa M; Zhao M; Sullivan J; Porsa E; Nijhawan AE
    Public Health Rep; 2019; 134(6):626-633. PubMed ID: 31530093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
    Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
    J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
    Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
    Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.